SCHEMBL13261556

SCHEMBL13261556

CCOC(=O)C(C(=O)c1ccc(CS(=O)O)cc1)c1ccc(OC)c(OC)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA12 O43570 3/20 0.43
▸ CA1 P00915 3/20 0.43
▸ CA2 P00918 3/20 0.43
▸ CA9 Q16790 3/20 0.43
▸ LMNA P02545 4/20 0.40
▸ SMN1; SMN2 Q16637 2/20 0.40
▸ HTT P42858 2/20 0.40
▸ NPC1 O15118 1/20 0.40
▸ ALDH1A1 P00352 3/20 0.40
▸ POLB P06746 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ MAPT P10636 3/20 0.39
▸ HIF1A Q16665 3/20 0.39
▸ GAA P10253 2/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ KDM4E B2RXH2 1/20 0.38
▸ ACHE P22303 1/20 0.38
▸ LDHA P00338 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13261549 0.85 CA12 (0.43) CA12CA1CA2CA9LMNA
SCHEMBL13228093 0.85 CTNNB1 (0.51) CA12CA1CA2CA9LMNA
SCHEMBL13261545 0.84 SLC6A2 (0.42) LMNASMN1; SMN2HTTALDH1A1MAPT
SCHEMBL13261834 0.83 MMP8 (0.38) LMNASMN1; SMN2HTTNPC1ALDH1A1
SCHEMBL13261551 0.83 L3MBTL1 (0.41) CA12CA1CA2CA9SMN1; SMN2
SCHEMBL13261592 0.83 CES2 (0.39) ALDH1A1CYP2C19
SCHEMBL13261661 0.83 LMNA (0.41) CA12CA1CA2CA9LMNA
SCHEMBL13261550 0.82 MMP8 (0.35) CA12CA1CA2CA9LMNA
SCHEMBL13261590 0.82 SLC6A2 (0.38) NPC1GAA
SCHEMBL13261650 0.81 EPHX2 (0.41) LMNAHTTALDH1A1POLBCYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7781592-B2 Thione derivative, method for the preparation thereof, and pharmaceutical composition containing the same CJ CHEILJEDANG CORPORATION (KR) 2010-08-24 — — US disclosed
US-20080090875-A1 Thione Derivative, Method For The Preparation Thereof, And Pharmaceutical Composition Containing The Same CJC CORPORATION (KR) 2008-04-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080090875-A1 Thione Derivative, Method For The Preparation Thereof, And Pharmaceutical Composition Containing The Same TPMT, TST, CYP3A5 CA12 2840/4885CA1 1852/4885CA2 1649/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback